Should patients with cirrhosis‑related ascites receive routine albumin infusion, or only when undergoing large‑volume paracentesis (>5 L) or having spontaneous bacterial peritonitis with renal‑risk features?

Albumin Transfusion in Cirrhosis-Related Ascites

Patients with cirrhosis and ascites do not require routine albumin infusion; albumin is mandatory only for large-volume paracentesis (>5 L) at 8 g per liter removed, and for spontaneous bacterial peritonitis at weight-based dosing (1.5 g/kg within 6 hours, then 1.0 g/kg on day 3). 1

Evidence-Based Indications for Albumin

Large-Volume Paracentesis (>5 L) – Mandatory

• Administer 8 g of albumin per liter of ascitic fluid removed when the total volume exceeds 5 L. This is a Level A1 recommendation from the American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL). 1

• The albumin should be given as 20% or 25% hyperoncotic solution, infused after the paracentesis is completed (not during), over 1–2 hours to prevent cardiac overload in patients with cirrhotic cardiomyopathy. 2, 3

• Without albumin replacement, post-paracentesis circulatory dysfunction (PPCD) occurs in 70–80% of patients versus approximately 18% when the recommended dose is given. Renal impairment develops in approximately 21% without albumin versus 0% with proper replacement. 2, 3

• For example, a 5 L paracentesis requires 40 g of albumin (approximately 200 mL of 20% albumin or 160 mL of 25% albumin). 1, 4

Paracentesis <5 L – Not Mandatory

• Albumin replacement is not required for paracentesis removing less than 5 L in uncomplicated cases, as these smaller volumes are not associated with significant hemodynamic changes. 1

• However, albumin at 8 g/L may be considered (but remains optional) for high-risk patients with acute-on-chronic liver failure or elevated risk of post-paracentesis acute kidney injury, even when <5 L is removed. 2, 4

Spontaneous Bacterial Peritonitis (SBP) – Mandatory

• Give 1.5 g/kg albumin within 6 hours of SBP diagnosis, followed by 1.0 g/kg on day 3. This is a strong recommendation with moderate-certainty evidence. 3, 4

• This regimen reduces renal impairment (approximately 10% versus 33%) and mortality (approximately 22% versus 41%) compared with antibiotics alone. 3

• The SBP dosing protocol is weight-based and distinct from the volume-based dosing used for paracentesis. 3, 4

Situations Where Albumin Is NOT Indicated

Uncomplicated Ascites Without Paracentesis

• Routine long-term albumin infusions are not recommended for patients with cirrhosis and ascites. The AASLD 2021 guidance explicitly states there are insufficient data to recommend long-term albumin use outside the setting of large-volume paracentesis. 1

• The ATTIRE trial (777 patients) demonstrated that daily albumin infusions targeting serum levels ≥3 g/dL showed no benefit in preventing infection, renal failure, or death, and resulted in significantly higher rates of pulmonary edema and fluid overload. 3

Refractory Ascites Management

• While one small cohort study (70 participants) suggested potential benefit from chronic albumin infusion (20 g twice weekly) in reducing 24-month hospital admissions and mortality in refractory ascites, the AASLD 2021 guidance concludes there are insufficient data to recommend this practice, and randomized controlled trials are needed. 1

Clinical Algorithm for Albumin Use in Ascites

Step 1: Identify the clinical scenario

• Large-volume paracentesis planned (>5 L)? → Albumin mandatory at 8 g/L removed 1
• Paracentesis <5 L in uncomplicated patient? → Albumin not required 1
• Paracentesis <5 L in high-risk patient (ACLF, high AKI risk)? → Consider albumin at 8 g/L 2, 4
• Spontaneous bacterial peritonitis diagnosed? → Weight-based albumin (1.5 g/kg → 1.0 g/kg day 3) 3, 4
• Uncomplicated ascites without intervention? → No albumin 1, 3

Step 2: Calculate the albumin dose

• For paracentesis >5 L: (Volume in liters) × 8 g = Total albumin dose in grams 1
• For SBP: (Patient weight in kg) × 1.5 g = Initial dose; (Patient weight in kg) × 1.0 g = Day 3 dose 3, 4

Step 3: Administer correctly

• Use 20% or 25% albumin solution only (5% albumin is inadequate) 2, 3
• Infuse after paracentesis completion, not during the procedure 2, 3
• Infuse slowly over 1–2 hours to avoid volume overload 2, 3

Step 4: Post-procedure management

• Restart diuretics within 1–2 days after paracentesis (spironolactone 100–400 mg plus furosemide 40–160 mg in a 100:40 ratio) to prevent rapid ascites re-accumulation, which occurs in approximately 93% without diuretics versus 18% with spironolactone. 3
• Monitor serum sodium daily for hyponatremia (occurs in approximately 17% without albumin versus 8% with albumin) 3
• Monitor serum creatinine for acute kidney injury 3

Critical Pitfalls to Avoid

• Never use synthetic colloids (dextran-70, polygeline, hydroxyethyl starch) as albumin substitutes for large-volume paracentesis >5 L. The EASL 2010 guidelines explicitly state these are not recommended because they are less effective in preventing PPCD, cause greater renin-angiotensin-aldosterone system activation, and lead to higher rates of hyponatremia (17% versus 8% with albumin). 1, 3

• Never underdose albumin (e.g., 4 g/L instead of 8 g/L). All major guidelines endorse the 8 g/L standard, and underdosing markedly increases PPCD incidence and renal complications. 1, 3

• Never infuse albumin rapidly. Rapid infusion can precipitate cardiac overload, especially in patients with cirrhotic cardiomyopathy; always infuse over 1–2 hours. 2, 3

• Never withhold paracentesis due to coagulopathy or thrombocytopenia. Routine correction of INR or platelet count before paracentesis is not recommended, even with severe coagulopathy (INR up to 8.7 or platelets as low as 19×10³/μL), as hemorrhagic complications are rare and show no correlation with coagulopathy degree. 2

• Never delay diuretic reinitiation after large-volume paracentesis. Ascites re-accumulates in approximately 93% of patients without diuretics versus 18% when diuretics are restarted within 1–2 days. 3

Special Considerations

Maximum Volume Per Session

• The AASLD 2021 guidance states there is no absolute volume limit for paracentesis in a single session when appropriate albumin is administered, but the risk of PPCD increases when >8 L is evacuated. 1, 2

• One recent study showed that limiting paracentesis to <8 L per session and providing higher albumin doses (approximately 9 g/L) may better preserve renal function and survival over 2 years. 1

Cost-Effectiveness

• Although albumin is more expensive than synthetic colloids, a health economic analysis demonstrated that albumin is more cost-effective because it reduces liver-related complications within 30 days, thereby lowering overall hospital costs. 1, 3

Hepatorenal Syndrome and Other Indications

• For hepatorenal syndrome type 1, albumin should be combined with a vasoconstrictor (preferably terlipressin). 3, 5

• For acute variceal hemorrhage, albumin is recommended as part of resuscitation, though exact dosing varies. 3